[1] Article Title: Pregnancy in congenital myasthenic syndrome
	•	Line(s): 1
	•	Section: Title Page / Header
	•	Quote(s): “Pregnancy in congenital myasthenic syndrome”

⸻

[2] Publication Year: 2013
	•	Line(s): 26
	•	Section: Title Page / Journal citation
	•	Quote(s): “J Neurol (2013) 260:815–819”

⸻

[3] Region: Europe
	•	Line(s): 20, 36–38
	•	Section: Author Affiliations
	•	Quote(s): “Groupe Hospitalier Pitié-Salpêtrière, Paris, France”

⸻

[4] Country: France
	•	Line(s): 36–38
	•	Section: Author Affiliations
	•	Quote(s): “Groupe Hospitalier Pitié-Salpêtrière, Paris, France”

⸻

[5] Coverage Area: National
	•	Line(s): 12–14, 55–56
	•	Section: Abstract, Introduction
	•	Quote(s): “…all patients with CMS listed in the French Registry…”; “…patients with CMS recorded in the French CMS database.”

⸻

[6] Study Design: Retrospective
	•	Line(s): 67, 145
	•	Section: Introduction, Discussion
	•	Quote(s): “We therefore retrospectively reviewed the medical, gynecological, and obstetrical history…”; “…only a retrospective study was feasible.”

⸻

[7] Study Population: Adult female patients with congenital myasthenic syndrome (CMS)
	•	Line(s): 70–71
	•	Section: Patients and Methods
	•	Quote(s): “…24 of the 26 adult female CMS patients recorded in the French database…”

⸻

[8] Population Characteristics: Age range 20–60 years; all female
	•	Line(s): 88
	•	Section: Results
	•	Quote(s): “Data was obtained from 24 patients, aged from 20 to 60 at inclusion (mean 37.3 years).”

⸻

[9] Data Source Type: Registry
	•	Line(s): 14, 56
	•	Section: Abstract, Introduction
	•	Quote(s): “…patients with CMS listed in the French Registry…”; “…recorded in the French CMS database.”

⸻

[10] Data Source Details: French CMS database; verified with patients
	•	Line(s): 14–15
	•	Section: Abstract
	•	Quote(s): “The data were reviewed with the assistance of the patients to insure accuracy.”

⸻

[11] Study Timeline Type: Retrospective
	•	Line(s): 67, 145
	•	Section: Introduction, Discussion
	•	Quote(s): “…retrospectively reviewed the medical… history of the patients…”; “…only a retrospective study was feasible.”

⸻

[12] Number of Sites: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[13] Study Start Year: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[14] Study End Year: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[15] Main Ethnicity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[16] Ethnicity Details: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[17] Disease Studied: Congenital Myasthenic Syndrome (CMS)
	•	Line(s): 1, 12
	•	Section: Title, Abstract
	•	Quote(s): “Pregnancy in congenital myasthenic syndrome”

⸻

[18] Diagnosis Method: Molecular analysis
	•	Line(s): 72
	•	Section: Patients and Methods
	•	Quote(s): “Diagnosis of CMS was confirmed by molecular analysis for all patients.”

⸻

[19] Diagnosis Criteria Details: Based on molecular confirmation
	•	Line(s): 72
	•	Section: Patients and Methods
	•	Quote(s): “Diagnosis of CMS was confirmed by molecular analysis for all patients.”

⸻

[20] Disease Phase: Chronic
	•	Line(s): 59, 108
	•	Section: Introduction, Results
	•	Quote(s): “…CMS is a rare… inherited disease…” and “…recovered their pre-pregnancy clinical status six months after the delivery.”

⸻

[21] Cohort Age Group: Adult
	•	Line(s): 70–71
	•	Section: Patients and Methods
	•	Quote(s): “…24 of the 26 adult female CMS patients…”

⸻

[22] Female % in Cohort: 100%
	•	Line(s): 70
	•	Section: Patients and Methods
	•	Quote(s): “…adult female CMS patients…”

⸻

[23] Consanguinity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR